1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAPKAPK2 (MK2)


MAP kinase-activated protein kinase 2 (MAPKAPK2) is an enzyme that in humans is encoded by the MAPKAPK2 gene. MAPKAP kinase-2 (MK2) is originally identified by its phosphorylation of glycogen synthase at serine-7 and the corresponding serine in a peptide (GS peptide-1) modelled after the N-terminus of glycogen synthase.

MAPKAP kinase-2 is a novel protein kinase activated by mitogen-activated protein kinase. This MAP kinase activated protein kinase, termed MAPKAP kinase-2, is distinguished from S6 kinase-II (MAPKAP kinase-1) by its response to inhibitors, lack of phosphorylation of S6 peptides and amino acid sequence.

MAPKAPK2 (MK2) 相关产品 (4):

Cat. No. Product Name Effect Purity
  • HY-12834A
    MK2-IN-1 hydrochloride Inhibitor 99.19%
    MK2-IN-1 hydrochloride 是MAPKAPK2(MK2)激酶高效选择性抑制剂,IC50值0.11uM。
  • HY-112457
    MK-2 Inhibitor III Inhibitor >99.0%
    MK-2 Inhibitor III (compound 16) 是一种具有口服活性的,选择性的,ATP 竞争性的 MAPKAP-K2 (MK-2) 抑制剂,IC50 值为 0.85 nM,MK-2 Inhibitor III 对 MK-3 (IC50=0.21 μM), MK-5 (IC50=0.081 μM), ERK2 (IC50=3.44 μM), MNK1(IC50=5.7 μM) 以及 CDK2, JNK2, IKK2, MSK1, and MSK2 也具有选择性。
  • HY-12834
    MK2-IN-1 Inhibitor
  • HY-108643
    CMPD1 Inhibitor >99.0%
    CMPD1 是一种选择性且非 ATP 竞争性的 p38 MAPK 介导的 MK2 磷酸化抑制剂,表观 Ki (Kiapp) 值为 330 nM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.